65,437 trials
Pancreatic Adenocarcinoma · Resectable Pancreatic Carcinoma
Primary: R0 Resection Rate Defined as Macroscopically Complete Tumor Removal With Negative Microscopic Surgical Margins by Pathologic Assessment — 42 percentage of participants…
Leukemia, Myeloid, Acute
Primary: Number of Participants With a Complete Response (CR) — 79; 71 Participants — p=0.482
Hepatitis B Vaccine
Primary: Number and Percentage of Participants With Anti-HBs Seroconversion at Month 7 — 75; 69 Participants
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome · Secondary Acute Myeloid Leukemia
Primary: Number of Participants With a Response — 3; 6; 7; 0 Participants
Malocclusion
Primary: Bracket Door Stability — 0.8 percentage of bracket doors
Rectal Cancer
Primary: The Number of Participants Experiencing Dose Limiting Toxicities (DLT) — 0; 0; 0 Participants
Gastrostomy
Primary: Number of Participants With Serious Device Related Adverse Events — 1; 5 Participants
Gastro-Enteropancreatic Neuroendocrine Tumor
Primary: Relative Lesion Counts Presented by Combination of Injected Peptide/Radioactivity Dose Ranges — 3.6; 3.8; 2.1; 2.6 Ratio
Plaque · Inflammation
Primary: Change in Oral Plaque — -1.05; -0.03 log(percentage) — p=0.001
Infection by Streptococcus Group B
Primary: Part A Number of Participants With Treatment Emergent Adverse Events — 6; 5; 5; 6 participants
COPD · Emphysema · Chronic Bronchitis
Primary: 6-Minute Walk Test Distance — 25; 37 meters — p=0.189
Childhood Obesity · Infant Development
Primary: Focus Group Recommendations to Improve Infant Formula Preparation Instructions — 60; 80; 100; 60 percentage of focus group participants
Impaired Glucose Tolerance
Primary: Change 2-hour Plasma Glucose (During Oral Glucose Tolerance Test). — 9.27; 9.11; 7.28; 8.32 mmol/L — p=0.0028
Eosinophilic Esophagitis (EoE)
Primary: Proportion of Participants Who Had Relapse During the Entire Week 36 Period — 0.43; 0.24 proportion of participants — p=0.131
Total Knee Arthroplasty
Primary: Extent of Motor Blockade — 18; 29; 13; 5 Participants — p=<0.01